✦ LIBER ✦

Impact of co-morbidities on gemcitabine as single agent chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Landre, T.; Chouahnia, K.; Pailler, M.-C.; Bouillet, T.; Andriambololona, V.; Zelek, I.; Sebbane, G.; Guetz, G. Des

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single agent Gemcitabine for elderly pat

✍ Burkes, R.L; Wilson, J; Shepherd, F.A; Spadafora, S; Iglesias, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Second-line treatment with single-agent

✍ van Putten, J.W.G; Baas, P; Codrington, H; Kwa, H.B; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Gemcitabine (GEM) as single agent in sec

✍ Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

P-551 Single-agent navelbine oral (NVBo)

✍ Parente, B.; Queiroga, H.; Espanhol, V.; Cunha, J.; Fernandes, A.; Barroso, A.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Single agent taxol (TAX) as second-line

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 167 KB

6605 POSTER Oral vinorelbine as single-a

✍ Mendez, M.; Andrade, J.; Esquerdo, G.; Morales, S.; Garcia-Gomez, R.; Garcia-Bue 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB